Cited by 526Nanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryAdvanced Drug Delivery Systems

Biodegradable nanoparticles for cytosolic delivery of therapeutics

Open access
VASIR, J, LABHASETWAR, V·2007·Advanced Drug Delivery Reviews

Abstract

Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment. To achieve efficient cytosolic delivery of therapeutics, different nanomaterials have been developed that consider the diverse physicochemical nature of therapeutics (macromolecule to small molecule; water soluble to water insoluble) and various membrane associated and intracellular barriers that these systems need to overcome to efficiently deliver and retain therapeutics in the cytoplasmic compartment. Our interest is in investigating PLGA and PLA-based nanoparticles for intracellular delivery of drugs and genes. The present review discusses the various aspects of our studies and emphasizes the need for understanding of the molecular mechanisms of intracellular trafficking of nanoparticles in order to develop an efficient cytosolic delivery system.

Integrity signals

Registry

Crossref · 10.1016/j.addr.2007.06.003

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-molecular-weight PLA has been used to produce non-dismantling surgical sutures and low-molecular-weight PLA as a slow-release drug-packaging agent.

    “High-molecular-weight PLA has been used to produce non-dismantling surgical sutures and low-molecular-weight PLA as a slow-release drug-packaging agent [51].”

    From Synthesis and Biological Application of Polylactic Acid (2020) · cites this paper as [51]

Cites

Flagged first, then by citations

2 of the 77 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
VASIR, J., & LABHASETWAR, V
Affiliations
Cleveland Clinic (US)
Corresponding author
LABHASETWAR, V
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2007-08-10
Volume
59
Issue
8
Pages
718-728
ISSN
0169-409X (ISSN-L)
OpenAlex
W2032965857
Cited by
526
References
77
Citations by year
2026: 5 · 2025: 16 · 2024: 29 · 2023: 25 · 2022: 20 · 2021: 24 · 2020: 28 · 2019: 29 · 2018: 33 · 2017: 22 · 2016: 35 · 2015: 28 · 2014: 43 · 2013: 41 · 2012: 27
FWCI
13.72
Type
journal article
Language
en
Open access
Locations
  • Advanced Drug Delivery Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Mental Health (R21 MH67525, R21MH067525)
  • National Cancer Institute (CA121751, R21CA121751)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB003975)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
biodegradable nanoparticles, cytosolic drug delivery, intracellular delivery, PLGA nanoparticles, intracellular trafficking, gene delivery
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Biocompatible Materials, Biological Transport, Biotransformation, Chemistry, Pharmaceutical, Cytosol, Delayed-Action Preparations, Drug Carriers, Particle Size, Polyesters, Polyethylene Glycols, Polyglycolic Acid, Polymers, Drug Design, Lactic Acid, Absorbable Implants, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review